| Ozempic | Wegovy | |
|---|---|---|
| Molecule | Semaglutide | Semaglutide |
| Main approval | Type 2 diabetes (adults) | Weight management (adults; ages 12+) |
| Outcome indications | CV events in type 2 diabetes with heart disease; kidney decline in type 2 diabetes with CKD | CV events in adults with heart disease and obesity or overweight; MASH with F2 to F3 fibrosis |
| Maintenance doses | 0.5, 1 or 2 mg weekly | 1.7 or 2.4 mg weekly; 7.2 mg (Wegovy HD) for adult weight management |
| Oral version | Ozempic tablets 1.5 to 9 mg daily (also Rybelsus) | Wegovy pill 1.5 to 25 mg daily |
| Self-pay (pen) | $349 (0.25 to 1 mg); $499 (2 mg) | $349 (0.25 to 2.4 mg); $399 (7.2 mg) |
| New-patient starter (pen) | $199 for 2 fills of 0.25 or 0.5 mg, through Dec 31, 2026 | $199 for 2 fills of 0.25 or 0.5 mg, through Dec 31, 2026 |
| Medicare GLP-1 Bridge | Not on the Bridge list | Covered (injection or tablet) if eligible |
Is Ozempic just Wegovy under another name?
They share a molecule, semaglutide, and a manufacturer, but they are separate products with separate FDA labels. Ozempic is a diabetes medicine; Wegovy is a weight-management medicine that also carries heart and liver indications.
The doses tell the story. Ozempic's maximum is 2 mg a week. Wegovy's usual maintenance dose is 2.4 mg, and adults on Wegovy for weight can go to 7.2 mg if they have tolerated 2.4 mg for at least 4 weeks and need more weight reduction. Neither label is meant to be swapped for the other. Product detail: Ozempic and Wegovy.
How do the dose ladders compare?
Both start at 0.25 mg weekly for 4 weeks and step up every 4 weeks. Ozempic stops climbing once blood sugar is controlled; Wegovy aims for a set maintenance dose.
| Weeks | Ozempic | Wegovy |
|---|---|---|
| 1 to 4 | 0.25 mg | 0.25 mg |
| 5 to 8 | 0.5 mg (may stay here) | 0.5 mg |
| 9 to 12 | 1 mg if more glucose control is needed (at least 4 weeks on 0.5 mg) | 1 mg |
| 13 to 16 | 2 mg if needed (at least 4 weeks on 1 mg) | 1.7 mg |
| 17 on | Maximum 2 mg | 2.4 mg recommended for weight (or 1.7 mg); optional 7.2 mg later |
For chronic kidney disease, Ozempic's label sets 1 mg weekly as the maintenance dose. Your prescriber may hold either drug at a lower dose if side effects get in the way.
Which one is approved for what?
Ozempic's three uses all require type 2 diabetes: blood sugar control, lowering cardiovascular events in people with heart disease (SUSTAIN 6, hazard ratio 0.74), and slowing kidney decline in people with chronic kidney disease (FLOW, hazard ratio 0.76).
Wegovy's uses do not require diabetes. It is approved for weight management, for cardiovascular risk reduction in adults with heart disease and obesity or overweight (the SELECT trial, hazard ratio 0.80), and as an injection for MASH with moderate to advanced fibrosis under accelerated approval. In STEP-1, Wegovy 2.4 mg produced a mean 14.9% weight reduction versus 2.4% on placebo at 68 weeks.
What do they cost without insurance?
At low and middle doses, NovoCare charges the same for both pens: $349 a month, with a $199 starter price for new patients' first two fills of 0.25 or 0.5 mg through December 31, 2026. The prices split at the top: Ozempic 2 mg is $499 a month, Wegovy at 2.4 mg stays at $349, and Wegovy HD is $399.
As arithmetic only, using NovoCare's prices read November 8, 2026:
- 12 Ozempic 1 mg fills at $349 = $4,188.
- 12 Ozempic 2 mg fills at $499 = $5,988.
- 12 Wegovy 2.4 mg fills at $349 = $4,188; 12 Wegovy HD fills at $399 = $4,788.
NovoCare defines a pen "month" as one box of 4 pens, so 12 fills cover 48 weeks. Tablets start at $149 a month at 1.5 mg for both brands; the Wegovy pill rises to $199 at 4 mg and $299 at 9 and 25 mg. NovoCare says prices will be updated after December 31, 2026.
Which one will insurance cover?
Coverage follows the label. Plans that cover diabetes drugs usually cover Ozempic for type 2 diabetes, while Wegovy depends on whether the plan covers weight-management drugs or the heart indication.
Two 2026 examples show the split. CNBC reported on October 13, 2026 that Walmart will offer Ozempic and Mounjaro at no cost to employees with type 2 diabetes in 2027, after prior authorization, while still excluding GLP-1s for weight loss. In Medicare, the GLP-1 Bridge covers Wegovy (injection or tablet), Foundayo and the Zepbound KwikPen at $50 a month through December 31, 2027 for eligible people. People with type 2 diabetes are excluded from the Bridge; Medicare.gov says their Part D plan might cover a GLP-1. See Medicare Part D and GLP-1s.
What about compounded semaglutide?
Compounded semaglutide is neither Ozempic nor Wegovy. It is made with the drug in Wegovy but is not the same product and is not FDA-approved, and FDA warns that some compounders use salt forms it calls different active ingredients. The semaglutide guide covers prices and regulation, and semaglutide vs Wegovy covers the naming confusion.
Do they have the same side effects?
The profiles are similar, with nausea the most common. Rates differ by dose and population: in Ozempic's diabetes trials, nausea affected 15.8% on 0.5 mg and 20.3% on 1 mg versus 6.1% on placebo; in Wegovy's 2.4 mg weight trials, 44% versus 16%. Both carry the boxed warning for thyroid C-cell tumors in rodents and the MTC and MEN 2 contraindication.
Frequently asked questions
Is Wegovy stronger than Ozempic?
Wegovy reaches higher doses. Ozempic's maximum is 2 mg weekly for type 2 diabetes. Wegovy's recommended maintenance dose for weight is 2.4 mg, and adults may go to 7.2 mg as Wegovy HD after at least 4 weeks on 2.4 mg if more weight reduction is needed. The doses follow different labels and are not interchangeable.
Can I take Ozempic for weight loss instead of Wegovy?
Ozempic's label covers type 2 diabetes, not weight management. A prescriber can use a drug outside its label, but insurers usually require a diabetes diagnosis for Ozempic, and the label's maximum dose is lower than Wegovy's. Wegovy is the semaglutide brand FDA approved for weight management, with its own dose schedule and self-pay program.
Do Ozempic and Wegovy cost the same?
At many doses, yes. NovoCare's self-pay prices, read November 8, 2026, are $349 a month for Ozempic 0.25 to 1 mg and for Wegovy 0.25 to 2.4 mg, with the same $199 starter fills for new patients. They diverge at the top: Ozempic 2 mg is $499 and Wegovy HD 7.2 mg is $399.
Does Medicare cover Ozempic or Wegovy?
The Medicare GLP-1 Bridge covers Wegovy injection or tablets, plus Foundayo and the Zepbound KwikPen, at a $50 monthly copay through December 31, 2027 for eligible enrollees. Ozempic is not on the Bridge list, and people with type 2 diabetes are not eligible for the Bridge, but their Part D plan might cover a GLP-1 such as Ozempic.
Is there a pill version of Ozempic and Wegovy?
Yes. Ozempic tablets (1.5, 4 and 9 mg daily) share a label with Rybelsus for type 2 diabetes. The Wegovy pill (1.5 mg rising to 25 mg daily) is approved for weight management and heart risk reduction and was first approved on December 22, 2025. Tablets and injections use different milligram amounts and are not substituted one for one.
Sources
- FDA label (DailyMed): Ozempic injection prescribing information — highlights revised 01/2025 (SPL effective June 1, 2026); read 2026-11-08
- FDA label (DailyMed): Wegovy injection and tablets prescribing information — label revised 06/2026; read 2026-11-08
- NovoCare: Ozempic savings offer and self-pay pricing — read 2026-11-08
- NovoCare: Wegovy savings offer and self-pay pricing — read 2026-11-08
- Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge) — read 2026-11-08
- CNBC: Walmart employee benefits add no-cost GLP-1s in 2027 — news report published October 13, 2026; read 2026-11-08
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index